Arrowhead Pharmaceuticals, Inc.
(NASDAQ : ARWR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -2.26%153.740.0%$1478.94m
NVAXNovavax, Inc. -2.23%77.7078.2%$560.04m
AMGNAmgen, Inc. -0.70%224.511.4%$535.31m
GILDGilead Sciences, Inc. -0.15%68.471.0%$518.79m
BIIBBiogen, Inc. -1.62%221.061.8%$508.65m
BNTXBioNTech SE 2.52%154.780.0%$458.72m
REGNRegeneron Pharmaceuticals, Inc. -2.05%608.762.7%$416.43m
ILMNIllumina, Inc. -4.81%347.423.3%$376.13m
VRTXVertex Pharmaceuticals, Inc. -2.14%224.781.9%$352.63m
SNSSSunesis Pharmaceuticals, Inc. -2.56%2.660.7%$185.94m
EXASEXACT Sciences Corp. -6.42%69.8717.9%$168.64m
INCYIncyte Corp. -1.51%74.202.4%$135.72m
ARNAArena Pharmaceuticals, Inc. -0.59%89.4213.7%$135.66m
ALNYAlnylam Pharmaceuticals, Inc. -3.80%131.348.2%$124.32m
BMRNBioMarin Pharmaceutical, Inc. -1.97%84.524.2%$108.78m

Company Profile

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA.